Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma
- PMID: 2107973
Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma
Abstract
Previously we showed that IL2 expanded tumor-infiltrating lymphocytes (TILs) from renal cell carcinoma mediated non-major histocompatibility complex-restricted cytotoxicity. Phenotypic analysis showed that cultured TILs were composed mostly of T-lymphocytes with varying numbers of CD4+, CD8+, and CD56+ (Leu19+) populations. Here we compared the cytolytic activity of the two predominant TIL subsets, CD3+CD4+ and CD3+CD8+, to that of the CD56+ populations. Using magnetic beads coated with antibodies to either CD4 or CD8, CD3+CD4+, and CD3+CD8+ TILs were isolated in a highly enriched form (greater than 92%) and could be expanded for over 40 days in vitro with 1000 units/ml IL2. In a 4-h 51Cr release assay the CD4+ and CD8+ TILs showed minimal lytic activity, whereas unseparated cells exhibited significant levels of non-major histocompatibility complex-restricted cytotoxicity. The lytic activity seen in the 4-h assay with unseparated TILs appeared to be related to the presence of CD56+ populations. With one exception none of the purified CD4+ or CD8+ TILs expressed any significant levels of CD56, while the unseparated TILs contained varying numbers of CD3+CD56+ and CD3-CD56+ populations. Cell-sorting experiments verified that the CD56+ populations were responsible for most of the lytic activity in 4 h even though CD3+CD56- cells represented the predominant cell type. Although CD3+CD56- TILs were minimally lytic in 4 h, we show here that both CD3+CD4+ and CD3+CD8+ subsets displayed substantial cytotoxicity in long-term assays. In the 18-h 51Cr release assay 5 of 6 CD4+ and 2 of 3 CD8+ TILs were lytic for the autologous tumor. In two cases, restimulation with the autologous tumor induced augmented cytolytic activity of TIL subsets and in one case induced lytic activity in 4 h. The cytotoxic activity of TIL subsets was further examined using a 72-h assay in which TILs were cocultured with a confluent layer of tumor cells. The degree of cytotoxicity was quantitated by measuring the amount of crystal violet dye that was incorporated by tumor cells which remained after the incubation period. CD4+ and CD8+ TILs typically caused greater than a 50% reduction of tumor cells in 3 days and the level of reduction was increased when IL2 was added to the cultures. All the CD4+ and CD8+ subset preparations were cytotoxic in the 3-day assay even though some were not lytic for certain targets in the 18-h 51Cr release assay.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.J Immunol. 1989 Nov 15;143(10):3404-11. J Immunol. 1989. PMID: 2509557
-
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.Cancer Res. 1991 Aug 15;51(16):4199-205. Cancer Res. 1991. PMID: 1868441 Clinical Trial.
-
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.Cancer Res. 1989 Nov 1;49(21):5979-85. Cancer Res. 1989. PMID: 2507139
-
Human cytotoxic effector cells: definition and analysis of activity.Allergol Immunopathol (Madr). 1991 Jul-Aug;19(4):145-56. Allergol Immunopathol (Madr). 1991. PMID: 1726345 Review.
-
Can the dual-functional capability of CIK cells be used to improve antitumor effects?Cell Immunol. 2014 Jan;287(1):18-22. doi: 10.1016/j.cellimm.2013.11.009. Epub 2013 Dec 8. Cell Immunol. 2014. PMID: 24355711 Review.
Cited by
-
Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.Clin Dev Immunol. 2012;2012:890178. doi: 10.1155/2012/890178. Epub 2012 Feb 6. Clin Dev Immunol. 2012. PMID: 22400040 Free PMC article. Review.
-
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.Cancer Immunol Immunother. 1994 Jul;39(1):15-21. doi: 10.1007/BF01517175. Cancer Immunol Immunother. 1994. PMID: 8044822 Free PMC article. Review. No abstract available.
-
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.Cancer Immunol Immunother. 2017 May;66(5):565-571. doi: 10.1007/s00262-017-1957-3. Epub 2017 Feb 9. Cancer Immunol Immunother. 2017. PMID: 28184970 Free PMC article.
-
Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.Urol Res. 1996;24(5):297-303. doi: 10.1007/BF00304780. Urol Res. 1996. PMID: 8931295
-
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.Cancer Immunol Immunother. 2015 Mar;64(3):357-66. doi: 10.1007/s00262-014-1638-4. Epub 2014 Dec 2. Cancer Immunol Immunother. 2015. PMID: 25445815 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials